# Ivabradine Versus Beta-blockers in the Treatment of Inappropriate Sinus Tachycardia

> **NCT01657136** · PHASE3 · COMPLETED · sponsor: **Policlinico Casilino ASL RMB** · enrollment: 20 (actual)

## Conditions studied

- Inappropriate Sinus Tachycardia

## Interventions

- **DRUG:** Ivabradine
- **DRUG:** Beta blocker

## Key facts

- **NCT ID:** NCT01657136
- **Lead sponsor:** Policlinico Casilino ASL RMB
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01657136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01657136, "Ivabradine Versus Beta-blockers in the Treatment of Inappropriate Sinus Tachycardia". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01657136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*